Related Experiment Video
Updated: Feb 10, 2026

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
Colorectal cancer vaccines: principles, results, and perspectives
Simone Mocellin1, Carlo Riccardo Rossi, Mario Lise
1Department of Oncological and Surgical Sciences, University of Padova, 35128 Padova, Italy. mocellins@hotmail.com
Abstract:
In the search for novel therapeutic approaches to treat patients with colorectal carcinoma, anticancer vaccination holds promise. A large body of preclinical and clinical evidence has demonstrated that the immune system can be polarized against malignant cells by means of several active specific immunotherapy strategies. Although no vaccination regimen can be currently recommended outside clinical trials, tumor response and immunologic findings observed in animal models and humans prompt researchers to explore further the antitumor potential of such biotherapy in an effort to reproduce in a larger set of patients the cascade of molecular events that characterizes the successful tumor immune rejection currently observed in a minority of vaccinated subjects. In this work, we summarize the principles and the main results of cancer vaccine strategies so far implemented for the treatment of patients with colorectal carcinoma. We also discuss the most recent preclinical tumor immunology insights that might change the way to design the next generation of cancer vaccines, hopefully improving the effectiveness of such a biotherapeutic approach.
Insights
Anticancer vaccines show promise for colorectal carcinoma treatment by activating the immune system. Further research into cancer vaccines aims to improve effectiveness and tumor rejection in more patients.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Colorectal carcinoma (CRC) remains a significant health concern, necessitating novel therapeutic strategies.
- Anticancer vaccination, a form of active specific immunotherapy, has emerged as a promising approach for CRC treatment.
- Preclinical and clinical studies indicate the potential of immune system polarization against malignant cells.
Purpose of the Study:
- To review current cancer vaccine strategies for colorectal carcinoma treatment.
- To discuss recent advancements in preclinical tumor immunology relevant to vaccine design.
- To explore future directions for enhancing cancer vaccine effectiveness.
Main Methods:
- Review of preclinical and clinical evidence on cancer vaccines for CRC.
- Analysis of immunologic findings from animal models and human trials.
- Synthesis of current tumor immunology insights.
Main Results:
- Cancer vaccination strategies have shown potential in eliciting antitumor responses.
- Observed tumor responses and immunologic findings in a subset of patients warrant further investigation.
- Current vaccination regimens are primarily confined to clinical trials.
Conclusions:
- Cancer vaccines represent a promising biotherapeutic approach for colorectal carcinoma.
- Further research is needed to optimize vaccine design and improve patient outcomes.
- Advancements in tumor immunology may lead to next-generation cancer vaccines with enhanced efficacy.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
The Uncertainty Principle
Hardy-Weinberg Principle
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
The Pauli Exclusion Principle

